Gene · 5891
Papers1,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of genomic phenotype and immunophenotype of acute respiratory distress syndrome using autophagy and metabolism-related genes. | Front Immunol | 2023 | 37936685 | PubTator, text mining | PubMed |
| The mechanism of the Shuang Bai Su Qing recipe in treating periodontitis based on network pharmacology and molecular docking technology. | Medicine (Baltimore) | 2023 | 37933027 | PubTator, text mining | PubMed |
| SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells. | Nat Immunol | 2023 | 37919524 | PubTator, text mining | PubMed |
| Combining single-cell RNA sequencing and population-based studies reveals hand osteoarthritis-associated chondrocyte subpopulations and pathways. | Bone Res | 2023 | 37914703 | PubTator, text mining | PubMed |
| Prediction and analysis of genetic effect in idiopathic pulmonary fibrosis and gastroesophageal reflux disease. | IET Syst Biol | 2023 | 37907428 | PubTator, text mining | PubMed |
| Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology. | World J Clin Cases | 2023 | 37900230 | PubTator, text mining | PubMed |
| Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma. | Sci Rep | 2023 | 37898675 | PubTator, text mining | PubMed |
| Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics. | Pharmaceutics | 2023 | 37896221 | PubTator, text mining | PubMed |
| Dysregulated microRNA Expression Relevant to TERT Promoter Mutations in Tonsil Cancer-A Pilot Study. | Life (Basel) | 2023 | 37895471 | PubTator, text mining | PubMed |
| Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes. | Molecules | 2023 | 37894687 | PubTator, text mining | PubMed |
| Aminopeptidase N/CD13 Crosslinking Promotes the Activation and Membrane Expression of Integrin CD11b/CD18. | Biomolecules | 2023 | 37892170 | PubTator, text mining | PubMed |
| Microglial Activation: Key Players in Sepsis-Associated Encephalopathy. | Brain Sci | 2023 | 37891821 | PubTator, text mining | PubMed |
| Autocrine regulation of tumor cell repopulation by Hsp70-HMGB1 alarmin complex. | J Exp Clin Cancer Res | 2023 | 37880798 | PubTator, text mining | PubMed |
| The Potential Mechanism of Curcumin in Treating Oral Squamous Cell Carcinoma Based on Integrated Bioinformatic Analysis. | Int J Genomics | 2023 | 37868072 | PubTator, text mining | PubMed |
| Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology. | Medicine (Baltimore) | 2023 | 37861538 | PubTator, text mining | PubMed |
| PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system. | APL Bioeng | 2023 | 37854060 | PubTator, text mining | PubMed |
| Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology. | Front Immunol | 2023 | 37849759 | PubTator, text mining | PubMed |
| Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review. | Front Pharmacol | 2023 | 37841935 | PubTator, text mining | PubMed |
| Cancer Metabolism as a Therapeutic Target and Review of Interventions. | Nutrients | 2023 | 37836529 | PubTator, text mining | PubMed |
| Influence of Diabetes Mellitus and Smoking on Pro- and Anti-Inflammatory Cytokine Profiles in Gingival Crevicular Fluid. | Diagnostics (Basel) | 2023 | 37835794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5891/papers?page=14